ADIPOQ and familial pancreatic carcinoma: Decreased adiponectin enhances the susceptibility to pancreatic cancer development and is associated with pancreatic cancer growth and dissemination by inhibiting the action of insulin, which can activate PI3K/AKT signaling [78].